arrow
Back
A

Astellas Pharma Inc

Scholars37
Papers15
Citations15
Related Papers (11)
Publication Date
Real-world treatment patterns for metastatic urothelial cancer in 5 European countries: EVEREST 2
err2026-05-11
err0
PREAI
errMaria De Santis; Neil Milloy; Maria Walley; Amber Simpson; Cameron Forshaw; Marthe Vuillet; Torsten Strunz-McKendry; Janet Kim; Marie-Catherine Thomas
errShare
errSave
A novel retinoic acid receptor-α inhibitor, AS4040605, inhibits ILC2 activity
err2025-07-01
err0
errOAAI
errHara-Tsuchiya, Chihiro; Ujihara, Satoru; Hirose, Sho-ichi; Kitanaga, Yukihiro; Jono, Katsuma; Sasaki-Iwaoka, Haruna
errShare
errSave
Melatonin induces urethral contraction and increases intraurethral pressure via MT1 receptor activation in female rats
err2025-07-01
err1
PREAI
errMatsui, Shigeo; Yanai-Inamura, Hiroko; Kajiro, Masashi; Takamatsu, Hajime; Tanahashi, Masayuki; Yokono, Masanori
errShare
errSave
Survey and Establishment of Points to Consider for Application of Analytical Techniques to Evaluate Protein Aggregates and Insoluble Particles in Biopharmaceuticals: Experiences in Japan Biopharmaceutical Consortium
err2025-04-03
err0
errOAAI
errShibata, H; Saitoh, S; Kiyoshi, M; Hayashi, Y; Inaba, K; Katsura, S; Sakurai, M; Komine, Y; Okabe, S; Ohbayashi, N; Kita, Y; Kito, H; Nakano, M; Miyamoto, K; Maruyama, A; Miyahara, Y; Noda, M; Nozawa, Y; Shimbo, K; Kojima, S; Honda, S; Torisu, T; Uchiyama, S; Ishii-Watabe, A
errShare
errSave
Maintenance therapy with the FMS-like tyrosine kinase 3 inhibitor gilteritinib in patients with FMS-like tyrosine kinase 3-internal tandem duplication acute myeloid leukemia: A phase 2 study
errCANCER
IF5.1
err2025-02-13
err0
errOAAI
errGyan, Emmanuel; Minden, Mark D.; Kubo, Kohmei; Rambaldi, Alessandro; Juliusson, Gunnar; Jadersten, Martin; Kelly, Richard J.; Szerafin, Laszlo; He, Wensheng; Gill, Stanley C.; Hill, Jason E.; Chen, Caroline; Delgado, David; Hasabou, Nahla
errShare
errSave
Optimizing CAR-T treatment: A T2EVOLVE guide to raw and starting material selection
err2024-11-01
err0
errOAAI
errNavarro, Sergio; Moukheiber, Carole; Sancho, Susana Inoges; Guillen, Marta Ruiz; de Cerio, Ascension Lopez-Diaz; Sanges, Carmen; Tanaka, Toshimitsu; Arnould, Sylvain; Briones, Javier; Dolstra, Harry; Hudecek, Michael; Choudhary, Rashmi; Schapitz, Inga; Juan, Manel; Worel, Nina; Ammar, Delphine; Luu, Maik; Mueller, Mirko; Schroeder, Bernd; Negre, Helene; Franz, Paul
errShare
errSave
Preliminary safety and clinical activity of ASP3082, a first-in-class, KRAS G12D selective protein degrader in adults with advanced pancreatic (PC), colorectal (CRC), and non-small cell lung cancer (NSCLC)
err2024-09-01
err6
PREAI
errPark, W.; Kasi, A.; Spira, A. I.; Berlin, J. D.; Wang, J. S.; Herzberg, B.; Kuboki, Y.; Kitano, S.; Pelster, M.; Goldman, J. W.; Morgensztern, D.; Kondo, S.; Janne, P. A.; Fujii, H.; Lee, H-J.; Gill, S.; Saci, A.; Lorusso, P.; Tolcher, A. W.
errShare
errSave
EV-302: Exploratory analysis of nectin-4 expression and response to 1L enfortumab vedotin (EV) plus pembrolizumab (P) in previously untreated locally advanced or metastatic urothelial cancer (la/mUC)
err2024-09-01
err5
PREAI
errPowles, T. B.; Van der Heijden, M. S.; Gupta, S.; Perez Valderrama, B.; Galsky, M. D.; Bedke, J.; Kikuchi, E.; Hoffman-Censits, J.; Rey, J. P. Maroto; Vulsteke, C.; Iyer, G.; Swami, U.; Shin, S. J.; Rodriguez-Vida, A.; Wozniak, M.; Moreno, B. Homet; Lu, J.; Yu, C.; Hogdal, L.; Loriot, Y.
errShare
errSave
Enzalutamide (enza) with or without leuprolide in patients (pts) with high-risk biochemically recurrent (hrBCR) prostate cancer (PC): EMBARK post hoc analysis by age
err2024-09-01
err0
PREAI
errShore, N. D.; De Giorgi, U.; Gleave, M. E.; Kalac, M.; Tang, Y.; Croitoru, R.; Rosales, M.; Huynh, M.; Tammela, T.; de Jong, I. Jan; Evans, C.; Carcano, F. M.; Freedland, S. J.
errShare
errSave
Phase I/II trial of ASP1570, a novel diacylglycerol kinase z inhibitor, in patients with advanced solid tumors
err2024-09-01
err0
PREAI
errOlson, D.; Dowlati, A.; Luke, J. J.; Mckean, M.; Yoshida, T.; Park, D.; Kitano, S.; Barve, M.; Kaneko, Y.; Koelsch, G.; Soukharev, S.; Takeshita, S.; Alsharif, N.; Hashemi, N.; Patel, M. R.
errShare
errSave
Zolbetuximab with gemcitabine plus nab-paclitaxel (GN) in first-line treatment of Claudin 18.2-positive metastatic pancreatic cancer (mPC): Phase II, open-label, randomized study
err2024-09-01
err1
PREAI
errPark, W.; O'Reilly, E. M.; Li, C-P.; Oh, D-Y.; Garcia-Carbonero, R.; Roth, G.; Nakajima, T.; Moran, D.; Yang, J.; Li, R.; Kunieda, F.
errShare
errSave